• PDF / 14,132,096 Bytes
• 332 Pages / 504.63 x 737.01 pts Page_size
• 50 Downloads / 226 Views

DOWNLOAD

REPORT

---

COPD Heterogeneity and Personalized Treatment

123

COPD

Sang-Do Lee Editor

COPD Heterogeneity and Personalized Treatment

Editor Sang-Do Lee Department of Pulmonary and Critical Care Medicine Asan Medical Center University of Ulsan College of Medicine Seoul South Korea

ISBN 978-3-662-47177-7    ISBN 978-3-662-47178-4 (eBook) DOI 10.1007/978-3-662-47178-4 Library of Congress Control Number: 2017947875 © Springer-Verlag Berlin Heidelberg 2017 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Printed on acid-free paper This Springer imprint is published by Springer Nature The registered company is Springer-Verlag GmbH Germany The registered company address is: Heidelberger Platz 3, 14197 Berlin, Germany

Preface

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Over the last few decades, the study of COPD has become one of the most rapidly developing fields in medicine. The recent years have provided clinicians and researchers with major advances in the understanding of underlying mechanisms in COPD. In the past decades, COPD was classified solely on the basis of the degree of airflow limitation. Nowadays, COPD is regarded as a heterogeneous disease, with multiple etiological factors, clinical phenotypes, and comorbidities. One of the main reasons for poor understanding and poor treatment is the heterogeneity of COPD. The strategy for the management of COPD is moving toward a more personalized approach compared with the historical approach. Dissecting the heterogeneity would lead to a better understanding and effective personalized treatment of COPD. Airway Vista, also known as Chronic Obstructive Airway Diseases Symposium, has been hosted by the Obstructive Lung Disease Research Foundation in South Korea since 2008. This academic event is designed to offer respiratory health professionals new horizons in